Gains against cardiovascular disease, especially in Western Europe, is likely a cause for the shift.
Loss of appetite and not eating are difficult aspects of cancer for patients' loved ones to understand. Continued and diligent nurse education can help both patients and families cope with this disturbing effect.
The simple childhood pleasure of a coloring book and crayons—or colored pencils, as in this case—provide the foundation of a unique support group for patients with cancer and their families.
Current sequencing technology has enabled an analysis of cancer evolution that directs research attention away from the search for genes that enable metastasis and toward genes that are mutated early during tumorigenesis.
As the American College of Surgeons' Commision on Cancer milestones approach, ASTRO publishes a template to ensure consistent, comprehensive survivorship care plans can be developed for cancer survivors whose treatment involved radiotherapy.
Oncology drug costs continue to rise, and the financial distress patients experience has led many to call for efforts to reduce oncology drug prices. Viable policy interventions will not be free and will involve tradeoffs, according to a team of experts.
A new technology detects disease biomarkers in the form of nucleic acids, which are the molecules that comprise DNA and RNA. The test zeroes in on microRNA, which can signal a wide range of diseases, including cancer.
Potential Drug Targets Are Identified With Finding That Genes in the Ly6 Gene Family Drive Tumorigenesis and Poor PrognosisFebruary 25, 2016
Lower patient survival and worse clinical outcomes across a variety of cancer types were correlated with increased expression of 4 genes in the Ly6 gene family. These findings came from an analysis of 130 gene expression studies from 10 solid cancers.
New research aims to flip wound-repair (M2 type) macrophages, which promote the growth of cancer, into wound-sterilization (M1 type) macrophages, which may aid the immune system in clearing cancer.
Analyzing tumor DNA fragments in the bloodstream, known as circulating tumor DNA (ctDNA), may offer a more complete view of a patient's cancer from a molecular perspective.
An exploration of the interaction between the protein produced by the common cancer-causing KRAS gene and the AGO2 protein may lead to the possibility of interrupting the KRAS-AGO2 interaction as a possible therapy.
Participation in human research may improve with full disclosure and increased transparency of the risks of participating in publicly shared, big-data research projects.
After experiencing the benefits of meditation to help himself cope with the stress of caring for patients with cancer, this oncologist leads classes teaching those patients to use the tool to better cope with their disease and its effects.
Nanoparticles that release a drug only when exposed to near-infrared (NIR) light are a promising drug-delivery agent developed by Canadian researchers.
Gatastatin, an inhibitor specific for γ-tubulin, known to be overexpressed in some cancer cells, has been identified and holds potential for the development of anticancer agents.
Why do the antibody drugs have such long names?
Optical probes that make cancer cells glow and improve surgical tumor removal are in phase I and II clinical trials in humans. The probes could be commonplace in the next 5 to 10 years, hypothesize the researchers.
Differences in Cancer Rates Seen Among Asian American and Native Hawaiian/Pacific Islander PopulationsJanuary 29, 2016
Significant differences in cancer rates were found between Asian Americans and Native Hawaiians/Pacific Islanders (AANHPIs), according to a special report within Cancer Facts & Figures 2016.
Teen girls living in high-poverty and in majority Hispanic communities had the highest rates of having received at least 1 dose of the HPV vaccine compared with those in low-poverty communities and in communities of other racial or ethnic compositions.
A new study suggests that cell-free DNA, tiny fragments of cells in the bloodstream that occur after cells die, may indicate the tissue-of-origin of a cancer, which can be unknown in some cases of metastatic disease.
Initiating a palliative care consultation in the ED improved quality of life and survival was not shortened in patients with advanced cancer.
Sources of stem cells used to treat bone marrow failure vary around the world, with bone marrow harvest more commonly used in areas with more resources. PBSCs are more commonly used in regions with limited resources.
Molecular and cellular events that drive premalignant progression are on the verge of being comprehensively characterized in a report that lays out an agenda for the immediate future of cancer prevention research.
Diclofenac, a commonly used NSAID, has significant anticancer properties. Preclinical and clinical data indicating its distinct anticancer effects were summarized by the Repurposing Drugs in Oncology project.
The Society for Cardiovascular Angiography and Interventions released an expert consensus statement providing guidance for managing the treatment of patients facing concomitant cardiovascular disease and cancer.
A new injectable agent causes cancer cells in a tumor to fluoresce, potentially enabling surgeons to locate and remove all of a cancerous tumor on the first attempt.
The cancer death rate has dropped by 23% since its peak in 1991, averting more than 1.7 million cancer deaths through 2012, with advances in cancer prevention, early detection, and treatment a part of this rate decline.
An antiscarring paste halted the fibrosis caused by the radiation used in cancer therapy when applied to the skin of mice, according to early findings of a recent study.
Researchers identified characteristics that may lead to low patient accrual for a clinical trial.
Researchers identified a protein that is essential for MYC to cause cancer in mouse models, and they believe, could be a target for anticancer therapy.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
- Immunotherapy and the Future of Prostate Cancer Treatment
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|